⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for newly diagnosed aml

Every month we try and update this database with for newly diagnosed aml cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Natural Killer Cell (CYNK-001) Infusions in Adults With AMLNCT04310592
Leukemia
Leukemia, Myelo...
Leukemia, Myelo...
Neoplasms by Hi...
Neoplasms
Immunosuppressi...
Immunologic Fac...
Physiological E...
Alkylating Agen...
Antimetabolites...
Antiviral Agent...
Analgesics, Non...
Anti-infective ...
Analgesics
Peripheral Nerv...
Hematologic Dis...
Hematologic Neo...
Leukemia in Rem...
Relapsed Adult ...
Refractory AML
CYNK-001
18 Years - 80 YearsCelularity Incorporated
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 MutationNCT02632708
Newly Diagnosed...
Untreated AML
AML Arising Fro...
AML Arising Fro...
AML Arising Aft...
AG-120
AG-221
cytarabine
daunorubicin
idarubicin
mitoxantrone
etoposide
18 Years - Servier
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard ChemotherapyNCT02752035
Acute Myeloid L...
Acute Myeloid L...
gilteritinib
azacitidine
18 Years - Astellas Pharma Inc
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)NCT00373529
Acute Myelogeno...
Acute Myeloid L...
clofarabine
60 Years - Sanofi
Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)NCT01829503
Acute Myeloid L...
decitabine and ...
Supportive Care
60 Years - University of Pittsburgh
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 MutationNCT02632708
Newly Diagnosed...
Untreated AML
AML Arising Fro...
AML Arising Fro...
AML Arising Aft...
AG-120
AG-221
cytarabine
daunorubicin
idarubicin
mitoxantrone
etoposide
18 Years - Servier
Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)NCT01829503
Acute Myeloid L...
decitabine and ...
Supportive Care
60 Years - University of Pittsburgh
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)NCT00373529
Acute Myelogeno...
Acute Myeloid L...
clofarabine
60 Years - Sanofi
Natural Killer Cell (CYNK-001) Infusions in Adults With AMLNCT04310592
Leukemia
Leukemia, Myelo...
Leukemia, Myelo...
Neoplasms by Hi...
Neoplasms
Immunosuppressi...
Immunologic Fac...
Physiological E...
Alkylating Agen...
Antimetabolites...
Antiviral Agent...
Analgesics, Non...
Anti-infective ...
Analgesics
Peripheral Nerv...
Hematologic Dis...
Hematologic Neo...
Leukemia in Rem...
Relapsed Adult ...
Refractory AML
CYNK-001
18 Years - 80 YearsCelularity Incorporated
Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid LeukemiaNCT04106076
Acute Myeloid L...
UCART123
18 Years - 65 YearsCellectis S.A.
Single Arm Study of Azacitidine and Venetoclax for Treatment of Newly Diagnosed Fit Acute Myeloid Leukemia PatientsNCT05471700
Leukemia, Myelo...
Azacitidine
Venetoclax
45 Years - 65 YearsZhujiang Hospital
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)NCT00373529
Acute Myelogeno...
Acute Myeloid L...
clofarabine
60 Years - Sanofi
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: